Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism

Harry R Büller, Hervé Décousus, Michael A Grosso, Michele Mercuri, Saskia Middeldorp, Martin H Prins, Gary E Raskob, Sebastian M Schellong, Lee Schwocho, Annelise Segers, Minggao Shi, Peter Verhamme, Phil Wells, Hokusai-VTE Investigators, Jørgen Lykke Jeppesen

1544 Citationer (Scopus)

Abstract

Whether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin in patients with venous thromboembolism is unclear.
OriginalsprogEngelsk
TidsskriftThe New England journal of medicine
Vol/bind369
Udgave nummer15
Sider (fra-til)1406-15
Antal sider10
ISSN0028-4793
DOI
StatusUdgivet - 10 okt. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism'. Sammen danner de et unikt fingeraftryk.

Citationsformater